Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

Actions

• 2024-09-24Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
• 2024-09-23Motion to reconsider laid on the table Agreed to without objection.
• 2024-09-23On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
• 2024-09-23Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5578)
• 2024-09-23DEBATE - The House proceeded with forty minutes of debate on H.R. 3884.
• 2024-09-23Considered under suspension of the rules. (consideration: CR H5578-5580)
• 2024-09-23Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
• 2023-08-25Placed on the Union Calendar, Calendar No. 132.
• 2023-08-25Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
• 2023-08-25Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-166.
• 2023-07-19Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
• 2023-07-19Committee Consideration and Mark-up Session Held.
• 2023-07-13Subcommittee Consideration and Mark-up Session Held
• 2023-07-13Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 28 - 0.
• 2023-06-09Referred to the Subcommittee on Health.

Showing 15 of 18 actions. Full history on Congress.gov.

CRS Summary

As of 2023-08-25 (07)

Cosponsors (3)

• DANNY DAVIS (D-IL)
• Earl Carter (R-GA)
• BARBARA LEE (D-CA)

Subjects

• Blood and blood diseases
• Health programs administration and funding
• Health promotion and preventive care
• Hereditary and development disorders
• Medical research